Chung Chow Chan

Therapeutic Delivery Solutions

Buch

Therapeutic Delivery Solutions presents a comprehensive review of the full range of potential medical therapeutic development solutions. The book discusses three therapeutic delivery platforms (Conventional Therapeutic Delivery System, Medical Device Therapeutic Delivery System, and Cellular Therapeutic Delivery) and their associated regulatory requirements. There is currently no other resource examining these three areas in one textbook. It allows development scientists, engineers and medical professionals more options to develop a therapeutic agent to its fullest potential and creates better and more creative therapeutic solutions. The book… Mehr

CHF 165.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

V105: Folgt in ca. 15 Arbeitstagen

Produktdetails

Weitere Autoren: Chow, Kwok / McKay, Bill / Fung, Michelle

ISBN: 978-1-118-11126-0
EAN: 9781118111260
Produktnummer: 15783526
Verlag: John Wiley & Sons Inc
Sprache: Englisch
Erscheinungsjahr: 2014
Seitenangabe: 424 S.
Masse: H24.3 cm x B15.6 cm x D2.8 cm 710 g
Gewicht: 710
Sonstiges: Professional & Vocational

Über den Autor

Chung Chow Chan is currently with CCC Consulting/Covar Inc and provides services for analytical method development and validation, pre-formulation, formulation development, and CMC strategy building. He was Senior Director with Azopharma and had managed the drug developments programs for Phase 1 Express projects and analytical development laboratory.Kwok Chow was the Senior Director of Global PDS Technology and Alliances at Patheon Inc. with the responsibility of developing/introducing new technologies, establishing strategic technical alliances and providing scientific input in the pharmaceutical development of challenging molecules. Currently he is the Director of Covar Inc. responsible for pharmaceutical consulting and formulation development services.Bill McKay has over 30 years of product development experience in the Orthopaedic device business developing orthopaedic implants and combination drug/device products. He is currently Vice President of Biologics Research and Development at Medtronic Spinal and Biologics where he has developed and launched several unique bone grafting technologies and is developing novel locally delivered pain therapies. He has more than 100 patents and applications.Michelle Fung is currently a Clinical Associate Professor in the Division of Endocrinology & Metabolism, Department of Medicine, at the University of British Columbia.